Global Health Faces Unprecedented Challenges at WHO Summit

The World Health Organization (WHO) is currently navigating a period of significant upheaval as international delegates convene for the 79th World Health Assembly. The organization's operational capacity is being tested by ongoing financial constraints, leadership uncertainties, and stalled negotiations on pandemic preparedness.

Following the recent withdrawal of the United States from the WHO, the organization now faces a considerable budget shortfall. While a new financial report indicates that 90 percent of the core budget for the 2026-2027 biennium is provisionally covered, nearly $740 million of this amount consists of non-binding pledges yet to be confirmed by donors. To bridge the funding gap, the WHO is seeking support from non-traditional contributors and international financial institutions. Member states are expected to gradually increase their mandatory contributions, aiming for these to constitute half of the core budget by the early 2030s.

To manage the financial deficit, the WHO is implementing significant workforce reductions, with approximately 23 percent of positions being eliminated. This downsizing, scheduled to continue through June, raises concerns about the organization's ability to respond effectively to emerging global health emergencies, particularly as humanitarian crises and climate-related disasters become more frequent. The independent oversight committee for the WHO has cautioned that scaling back emergency response capabilities for financial reasons could lead to serious consequences.

In response to these challenges, the WHO is restructuring its workforce distribution, strengthening its regional offices and country teams. This shift is intended to increase flexibility and allow for more autonomous decision-making at the regional level, while the Geneva headquarters will focus on gathering health data and advancing global pandemic preparedness initiatives.

On the policy front, negotiations over the Pathogen Access and Benefit Sharing (PABS) system are at a standstill. The PABS system is designed to facilitate the swift sharing of dangerous pathogen samples and to ensure that the resulting vaccines and treatments are distributed equitably worldwide. However, these talks have stalled, with developing countries seeking binding legal guarantees for fair access to medical countermeasures. Many European nations have expressed reservations about enforceable benefit-sharing provisions, citing concerns over the competitiveness of their domestic pharmaceutical industries. Despite the lack of progress, the European Union remains committed to reaching a binding agreement, but consensus will require significant compromise and time is of the essence.

Meanwhile, the process to select the next Director-General of the WHO has begun, as member states consider candidates who can combine political acumen with strong financial oversight. Among the names being discussed are Indonesia's health minister, Sania Nishtar of Pakistan, and the current WHO regional director Hanan Balkhy. In Germany, several political and health leaders have also been mentioned as possible contenders, reflecting the country's desire to play a more prominent role in global health governance. However, the likelihood of securing the necessary diplomatic support for any particular candidate remains uncertain.

The incoming WHO leadership will inherit a host of unresolved challenges, including balancing demands for equitable access to healthcare in developing nations with the expectations of major financial contributors. Efforts are also ongoing to encourage the United States to re-engage with the WHO, despite its continued participation in the Pan American Health Organization (PAHO).

As the world confronts ongoing and emerging health threats, the future effectiveness of the WHO will depend on securing stable funding, achieving global consensus on pandemic preparedness, and rebuilding public confidence in the organization's mission and leadership.